PAVBLU
Amgen Inc.
Application Filed: 2022-04-08
Trademark Application Details
Mark For: PAVBLU™ trademark registration is intended to cover the categories of
| Website |
www.amgen.com
 |
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97353493 |
| Mark Literal Elements | PAVBLU |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | INTENT TO USE SECTION 2023-12-12 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Elsa D. Lemoine |
| Attorney Docket Number | TM-2177-US-1 |
Timeline
| 2022-04-08 | Application Filed |
| 2022-04-12 | Location: NEW APPLICATION PROCESSING |
| 2022-04-12 | Status: Live/Pending |
| 2022-04-12 | Transaction Date |
| 2023-04-04 | Published |
| 2023-12-12 | Location: INTENT TO USE SECTION |
| 2024-04-15 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Amgen Inc. |
| Address | One Amgen Center Drive Thousand Oaks, CALIFORNIA UNITED STATES 91320-1799 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2022-04-08 | |
| Drawing | 2022-04-08 | |
| XSearch Search Summary | 2022-12-20 | |
| Non-Final Action | 2022-12-21 | |
| Public Note | 2022-12-21 | |
| Response to Office Action | 2023-02-20 | |
| Amendment and Mail Process Complete | 2023-02-22 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-03-01 | |
| Notice of Publication | 2023-03-15 | |
| Notification Of Notice of Publication | 2023-03-15 | |
| OG Publication Confirmation | 2023-04-04 | |
| Notice of Allowance | 2023-12-12 | |
| Extension of Time to File SOU | 2024-04-15 | |
| ITU Extension Approval | 2024-04-16 | |
| ITU Unit Action | 2024-04-16 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-04-16 | |
| SOU TEAS EXTENSION RECEIVED | 2024-04-15 | |
| SOU EXTENSION 1 GRANTED | 2024-04-15 | |
| SOU EXTENSION 1 FILED | 2024-04-15 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-12-12 | |
| TTAB RELEASE CASE TO TRADEMARKS | 2023-11-01 | 287397 |
| OPPOSITION TERMINATED NO. 999999 | 2023-11-01 | 287397 |
| OPPOSITION DISMISSED NO. 999999 | 2023-11-01 | 287397 |
| OPPOSITION INSTITUTED NO. 999999 | 2023-09-28 | 287397 |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2023-04-27 | |
| PUBLISHED FOR OPPOSITION | 2023-04-04 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-04-04 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-03-15 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-02-28 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-21 | |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-02-20 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-20 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-12-21 | |
| NON-FINAL ACTION WRITTEN | 2022-12-21 | |
| NON-FINAL ACTION E-MAILED | 2022-12-21 | |
| ASSIGNED TO EXAMINER | 2022-12-14 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-04-12 | |
| NEW APPLICATION ENTERED IN TRAM | 2022-04-12 | |
| NEW APPLICATION ENTERED | 2022-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 